PharmaRelations ApS Financials, key figures and credit report
Gross profit 16 777.5 kDKK FY 2025 -25% vs 2024
EBIT -1 212.6 kDKK FY 2025 -448.4% vs 2024
Net debt -1 938.2 kDKK FY 2025 -122% vs 2024
Quick ratio 2.4 FY 2025 +0.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 20 105.09 | 23 599.55 | 23 251.52 | 22 361.03 | 16 777.51 |
| Employee benefit expenses | -16 735.56 | -22 633.82 | -22 218.78 | -22 012.99 | -17 990.12 |
| Total depreciation | -71.43 | -71.43 | -71.43 | ||
| EBIT | 3 298.10 | 894.30 | 961.32 | 348.04 | -1 212.62 |
| Other financial income | 5.02 | ||||
| Other financial expenses | -24.34 | -28.64 | -64.68 | -26.73 | -24.45 |
| Pre-tax profit | 3 273.76 | 865.66 | 896.64 | 326.33 | -1 237.07 |
| Income taxes | - 720.21 | - 191.07 | - 197.25 | -72.64 | 274.38 |
| Net earnings | 2 553.55 | 674.59 | 699.39 | 253.69 | - 962.69 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Goodwill | 142.86 | 71.43 | |||
| Intangible assets total | 142.86 | 71.43 | |||
| Tangible assets total | |||||
| Investments total | 151.71 | 246.64 | 212.51 | 212.28 | 218.65 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 6 611.45 | 7 619.78 | 8 018.00 | 7 531.68 | 5 391.34 |
| Prepayments and accrued income | 101.50 | 188.94 | 496.23 | 533.20 | 386.32 |
| Current other receivables | 0.22 | 8.50 | 0.20 | 0.20 | |
| Current deferred tax assets | 14.75 | 37.82 | 456.15 | ||
| Short term receivables total | 6 712.95 | 7 808.94 | 8 537.47 | 8 102.89 | 6 234.01 |
| Cash and bank deposits | 2 047.46 | 459.85 | 1 239.71 | 3 475.39 | 3 084.24 |
| Cash and cash equivalents | 2 047.46 | 459.85 | 1 239.71 | 3 475.39 | 3 084.24 |
| Balance sheet total (assets) | 9 054.98 | 8 586.86 | 9 989.68 | 11 790.57 | 9 536.91 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 2 344.15 | 4 897.69 | 5 572.28 | 6 271.67 | 6 525.36 |
| Profit of the financial year | 2 553.55 | 674.59 | 699.39 | 253.69 | - 962.69 |
| Shareholders equity total | 4 947.69 | 5 622.28 | 6 321.67 | 6 575.36 | 5 612.67 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 30.17 | 56.79 | 17.78 | ||
| Current trade creditors | 377.86 | 779.50 | 964.81 | 454.89 | 1 397.80 |
| Current owed to group member | 35.00 | 2 602.50 | 1 146.08 | ||
| Short-term deferred tax liabilities | 676.21 | 71.95 | |||
| Other non-interest bearing current liabilities | 3 023.05 | 2 056.33 | 2 650.42 | 2 157.81 | 1 380.37 |
| Current liabilities total | 4 107.28 | 2 964.58 | 3 668.01 | 5 215.21 | 3 924.24 |
| Balance sheet total (liabilities) | 9 054.98 | 8 586.86 | 9 989.68 | 11 790.57 | 9 536.91 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated